Symposier - Rheumatoid Arthritis - Mayo Clinic
Links shared publicly online about this topic.
- 609total visits
Symposier - Rheumatoid Arthritis - Mayo Clinic
View full resource at symposier.com
Tags: Edema, Pain, Joint, Arthritis, Rheumatoid Arthritis, Rheumatologist, Mayo Clinic, Rheumatology
Most Recently Shared on January 3, 2011 at 2:58 am By:
report to the Rheumatologist early within few weeks after getting joint pain, swelling and stiffness to get cured... http://fb.me/z9NuIg8T
| Regenexx™
regenexx.com — “Here's an article that appeared in a Cord Blood newsletter, thought the blog might find it interesting... Clinical Research on Stem Cells in Orthopedic” View full resource at regenexx.com
Most Recently Shared on April 25, 2012 at 5:28 pm By:
Hip stem Cell Injections-Are the Cells Getting where they Need to Go? | Regenexx™
regenexx.com — “A physicians describes new methods for injecting stem cells into hips with arthritis.” View full resource at regenexx.com
Most Recently Shared on April 24, 2012 at 9:27 am By:
Oral Bacteria Linked to Arthritic Joint Destruction
painlive.com — “Oral bacteria may be present in the synovial fluid of patients with arthritis and could be a contributing factor to joint failure, according to a pilot study published in the April 2012 issue of the Journal of Clinical Rheumatology.” View full resource at painlive.com
Most Recently Shared on April 19, 2012 at 7:10 pm By:
Oral Bacteria Linked to Arthritic Joint Destruction http://t.co/21KNtr88
Exactech selects MMI to evaluate novel cartilage repair treatment
news-medical.net — “Medical Metrics Inc, (MMI), an experienced provider of medical imaging core lab services for global clinical trials, has been selected by Exactech, Inc. to conduct an independent evaluation of medical images from the BiPhasic Cartilage Repair Implant (BiCRI) IDE Clinical Trial approved by the Taiwan FDA.” View full resource at news-medical.net
Most Recently Shared on April 19, 2012 at 10:04 am By:
Arthritis News: Exactech selects MMI to evaluate novel cartilage repair treatment: Medical Metrics Inc, (MMI), a... http://t.co/NA1mVfyv
Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients
news-medical.net — “Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed an Investigational New Drug application with the U.S. Food and Drug Administration to initiate a Phase IIb multi-center, 100-patient clinical trial.” View full resource at news-medical.net
Most Recently Shared on April 18, 2012 at 4:01 pm By:
Diabetes News: Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients:... http://t.co/ol32Ok8K
Why nuts should be part of your diet | BJC Health Connected Care
bjcconnectedcare.com — “By Monica Kubizniak, Dietitian http://youtu.be/xaQVzdre7r8 Monica Kubizniak is a dietitian at BJC Health. BJC Health provides a connected care” View full resource at bjcconnectedcare.com
Most Recently Shared on April 14, 2012 at 3:26 am By:
Symposier - The Healthexcel System of Metabolic Typing, A vision of Possibilities with Bill Wolcott
symposier.com — “Uploaded and shared in Youtube by: HawthornUniversity — William Wolcott worked with Dr. William Donald Kelly, who was one of the early nutritional cancer doctors. Wolcott, while working as the clinic's problem solver, realized that there were various types of information based upon metabolism that would determine which type of diet and supplements would optimize health in specific people. Based on over 30 years of clinical and technical experience in custom designing Metabolic Typing® progr” View full resource at symposier.com
Most Recently Shared on March 30, 2012 at 10:33 pm By:
Symposier Endocrino Health Site
The Healthexcel System of Metabolic Typing, A vision of Possibilities with Bill Wolcott http://t.co/NYAelhuS
Clinical Response to Infliximab in Patients With RA - QualityPoint Technologies
qualitypointtech.net — “Are antinuclear antibodies or anti-double-stranded DNA antibodies associated with the clinical efficacy of IFX? Arthritis Research & Therapy” View full resource at qualitypointtech.net
Most Recently Shared on March 28, 2012 at 2:00 pm By:
Clinical Response to Infliximab in Patients With RA: Are antinuclear antibodies or anti-double-stranded DNA antibo... http://t.co/aXnDzFG4
Positive results from Amgen's AMG 145 Phase 1b study on patients with LDL-C
news-medical.net — “Amgen announced today positive results from a Phase 1b clinical study of AMG 145, an investigational PCSK9 inhibitor, in patients with high cholesterol who were taking statins. The study demonstrated that multiple doses of AMG 145 significantly reduced serum low density lipoprotein cholesterol (LDL-C), also known as "bad" cholesterol, by up to 81 percent versus placebo (maximum reduction) in subjects on low to moderate doses of statins/” View full resource at news-medical.net
Most Recently Shared on March 26, 2012 at 8:32 am By:
Arthritis News: Positive results from Amgen's AMG 145 Phase 1b study on patients with LDL-C: Amgen announced tod... http://t.co/ZuH7jy7d
Medgenics to commence EPODURE Biopumps Phase IIa study in ESRD-related anemia
news-medical.net — “Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced receipt of clearance from the Israeli Ministry of Health to initiate a Phase IIa clinical study evaluating the safety and efficacy of sustained erythropoietin therapy produced and delivered by the Company's EPODURE Biopumps.” View full resource at news-medical.net
Most Recently Shared on March 26, 2012 at 4:52 am By:
Medgenics to commence EPODURE Biopumps Phase IIa study in ESRD-related anemia: Medgenics, Inc., the developer of... http://t.co/H0y4VuEt
A rare forum on stem cell biology, engineering and clinical translation
news-medical.net — “On March 23, during the 41st Annual Meeting & Exhibition of the American Association for Dental Research (AADR), held in conjunction with the 36th Annual Meeting of the Canadian Association for Dental Research, a symposium titled "TMJ: Stem Cell Biology and Engineering toward Clinical Translation" will provide a rare forum for multidisciplinary discussion of the biology, engineering and clinical translation of fundamental discoveries towards novel clinical therapy.” View full resource at news-medical.net
Most Recently Shared on March 22, 2012 at 1:55 pm By:
Arthritis News: A rare forum on stem cell biology, engineering and clinical translation: On March 23, during the... http://t.co/NFUi6k8N
Research and Markets: Arthritis Global Clinical Trials Review, H1, 2012 - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: Research and Markets has announced the addition of GlobalData's new report "Arthritis Global Clinical Trials R” View full resource at finance.yahoo.com
Most Recently Shared on March 19, 2012 at 5:19 pm By:
Arthritis OW Active Health Library and OW Health
Research and Markets: Arthritis Global Clinical Trials Review, H1, 2012: Research and Markets has announced the ... http://t.co/XVaLIeKE
Research and Markets: Arthritis Global Clinical Trials Review, H1, 2012 | Business Wire
businesswire.com — “Research and Markets(http://www.researchandmarkets.com/research/de43a2/arthritis_global_c) has announced the addition of GlobalData's new report "” View full resource at businesswire.com
Most Recently Shared on March 19, 2012 at 3:10 pm By:
Research and Markets: Arthritis Global Clinical Trials Review, H1, 2012 http://t.co/jnvcbN0R
Positive data from VBL Therapeutics' VB-201 Phase 2 study on psoriasis, atherosclerosis
news-medical.net — “VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated with atherosclerotic lesions as measured by PET-CT imaging.” View full resource at news-medical.net
Most Recently Shared on March 17, 2012 at 7:37 am By:
Arthritis News: Positive data from VBL Therapeutics' VB-201 Phase 2 study on psoriasis, atherosclerosis: VBL The... http://t.co/eCFxg2Bp
FDA arthritis advisory panel votes to continue anti-NGF clinical trials
endocrinetoday.com — “An FDA Arthritis Advisory Committee voted 21-0 to continue development trials for the anti-nerve growth factor class of drugs developed as pain reli” View full resource at endocrinetoday.com
Most Recently Shared on March 17, 2012 at 12:16 am By:
FDA arthritis advisory panel votes to continue anti-NGF clinical trials http://t.co/AVA0SWq6
Advertisement
